Mohan et al. [48] published a study in 2020 on the measurement of serum levels of EGFR mRNA expression, attempting to emphasize its value as a predictor of response to treatment and survival in non-small cell lung cancer types. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.